Skip to main content

Day: November 1, 2024

Partners Value Investments L.P. Announces Changes to Internal Group Capital Structure

TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (TSXV: PVF.UN, PVF.PR.U) (the “Partnership”), Partners Value Investments Inc. (TSXV: PVF.WT, PVF.PR.V) (“PVII”) and Partners Value Split Corp. (TSX: PVS.PR.G, PVS.PR.H, PVS.PR.I, PVS.PR.J, PVS.PR.K, PVS.PR.L) (“PV Split” and together with the Partnership and PVII, the “PVI Group”) together announce the completion of a share capital reorganization involving a change in how the Partnership owns its interest in PVII and how PVII owns its interest in PV Split. Pursuant to the reorganization, among other things, PVII amended its articles to: (a) redesignate the voting common shares held by the Partnership (“Common Shares”) as Class A restricted voting shares, which have substantially the same terms as the Common Shares but are entitled to elect 50% of the directors...

Continue reading

The New America High Income Fund, Inc. Declares Distribution

BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) — The New America High Income Fund, Inc. (the “Fund”) (NYSE: HYB) announced today that it will pay a distribution of $.04 per share on the company’s common stock on November 29, 2024 to common shareholders of record as of the close of business on November 15, 2024. The ex-dividend date will be November 15th. The Fund has released updated portfolio data which can be found on the Fund’s website at www.newamerica-hyb.com. The New America High Income Fund, Inc. is a diversified, closed-end management investment company with a leveraged capital structure. The Fund’s investment adviser is T. Rowe Price Associates, Inc. (“T. Rowe Price”). As of September 30, 2024, T. Rowe Price and its affiliates managed approximately $1.6 trillion of assets, including approximately $20 billion of “high yield” investments....

Continue reading

Lumine Group Inc. Announces Results for the Three and Nine Months Ended September 30, 2024

TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) — Lumine Group Inc. (“Lumine Group” or “the Company”) (TSXV:LMN) announces financial results for the three and nine months ended September 30, 2024. All amounts referred to in this press release are in US dollars unless otherwise stated. The following press release should be read in conjunction with the Company’s unaudited condensed consolidated interim financial statements for the three and nine months ended September 30, 2024, and management’s discussion and analysis (“MD&A”) for the three and nine months ended September 30, 2024, which can be found on SEDAR+ at www.sedarplus.ca. Additional information about Lumine Group is also available on SEDAR+ and on Lumine Group’s website www.luminegroup.com. Q3 2024 Headlines:Revenue grew 35% to $177.3 million compared to $131.3 million in...

Continue reading

Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q

FLORHAM PARK, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company, announced today it received a letter dated October 31, 2024, from Nasdaq, Inc. informing the Company that it had regained compliance with Nasdaq Listing Rule 5250(c)(1). The Company filed the following on October 29, 2024, with the Securities and Exchange Commission: (i) restated audited consolidated financial statements for the fiscal years ended December 31, 2023 and 2022 and restated quarterly financial statements for the periods ended March 31, 2023; June 30, 2023; September 30, 2023; March 31, 2022, June 30, 2022, and September 30, 2022 on Form 10-K/A; (ii) restated quarterly consolidated financial statements for the three months ended March 31, 2024 on Form 10-Q/A; and (iii) quarterly...

Continue reading

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 01, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company developing exosome-based therapies for the multi-billion dollar regenerative medicinei market, is pleased to announce, further to its press release dated September 26, 2024 (the “September 26 Release”), the closing of the final tranche of its previously announced non-brokered private placement (the “Offering”) for gross proceeds of $127,499.90 (“Tranche 2”). In the Offering, the Company raised aggregate gross proceeds of $1,737,647.45 through the issuance of 3,159,359 Units. Capitalized terms not otherwise defined herein have the meanings attributed to them in the September 26 Release. “We are delighted with the success closing of our Private Placement...

Continue reading

LeMaitre to Participate at Upcoming Investor Conferences in November

BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November. UBS Global Healthcare Conference Wednesday, November 13, 2024 Terranea Resort, Rancho Palos Verdes, CA David Roberts, President, will present at 7:15 AM PT Stifel’s 2024 Healthcare Conference Tuesday, November 19, 2024 Lotte NY Palace Hotel, New York City David Roberts, President, will present at 1:50 PM ET Wolfe Research Healthcare Conference 2024 Wednesday, November 20, 2024 Wolfe Research HQ, New York City David Roberts, President, will present at 2:00 PM ET About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people...

Continue reading

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

SAN DIEGO and LONDON, Nov. 01, 2024 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced the restructuring of a portion of its financial obligations, enhancing its balance sheet and liquidity. The Company has restructured the $2.65 million loan note with Nirland Limited (“Nirland”) and secured $1.2 million in new promissory notes through separate agreements with third parties. Conduit entered into a $2.65 million loan note with Nirland on August 6, 2024, which was subject to (i) a mandatory 75% repayment clause on new funding, and (ii) a right of first refusal for Nirland on any future fundraising. Conduit and Nirland have re-negotiated the terms of the note to remove these restrictive clauses enabling Conduit flexibility to raise new financing. The note is now convertible...

Continue reading

HOME FEDERAL BANCORP, INC. OF LOUISIANA ANNOUNCES APPROVAL OF STOCK REPURCHASE PROGRAM

SHREVEPORT, LA, Nov. 01, 2024 (GLOBE NEWSWIRE) — For Immediate Release Home Federal Bancorp, Inc. of Louisiana (the “Company”) (NASDAQ: HFBL), the holding company for Home Federal Bank, announced today that its Board of Directors on October 31, 2024, approved the Company’s thirteenth stock repurchase program. The new repurchase program provides for the repurchase of up to 100,000 shares, or approximately 3.0% of the Company’s outstanding common stock from time to time, in open market or privately negotiated transactions. The stock repurchase program does not have an expiration date. Home Federal Bancorp, Inc. of Louisiana is the holding company for Home Federal Bank which conducts business from its ten full-service banking offices and home office in northwest Louisiana. Statements contained in this news release which are not historical...

Continue reading

LogicMark, Inc. Announces Adoption of Shareholder Rights Agreement

LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) — LogicMark, Inc. (Nasdaq: LGMK), (“LogicMark” or the “Company”), a provider of personal safety, emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced that it has entered into a Rights Agreement with Nevada Agency and Transfer Company (the “Rights Agreement”) to protect shareholder rights and long-term shareholder value. This decision has been taken in response to recent actions by Winvest Investment Fund Management Corp. (“Winvest”), which recently disclosed in public filings with the U.S. Securities and Exchange Commission (“SEC”) that it (i) purportedly owns approximately 67% of LogicMark’s common stock (“Common Stock”) and (ii) attempted to implement significant changes to the Company’s...

Continue reading

Orca Energy Group Inc. Announces an Operational Update

TORTOLA, British Virgin Islands, Nov. 01, 2024 (GLOBE NEWSWIRE) — November 1, 2024: Orca Energy Group Inc. (“Orca” or the “Company“) and includes its subsidiaries and affiliates, including PanAfrican Energy Tanzania Limited (“PAET“) and Pan African Energy Corporation (Mauritius) (“PAEM“) (TSX-V: ORC.A, ORC.B) announces an operational update. Unless otherwise stated, all amounts referred to herein are expressed in United States dollars (“$”). Songas Update On October 30, 2024, PAET was advised by Songas Limited (“Songas”) that the Interim Power Purchase Agreement (“PPA”) will expire on October 31, 2024. At midnight on October 31, 2024, Songas shutdown the Songas Power Plan and it is unknown how long this will be in force. In the event that a new PPA is not entered into,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.